Granulocyte colony-stimulating factor reverses cytopenia and may permit cytogenetic responses in patients with chronic myeloid leukemia treated with imatinib mesylate

Haematologica. 2003 Feb;88(2):227-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzamides
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Neutropenia / chemically induced
  • Neutropenia / drug therapy*
  • Philadelphia Chromosome
  • Piperazines / therapeutic use
  • Piperazines / toxicity*
  • Pyrimidines / therapeutic use
  • Pyrimidines / toxicity*
  • Recurrence
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / drug therapy*

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Granulocyte Colony-Stimulating Factor
  • Imatinib Mesylate